The Electronic Common Technical Document (eCTD) is the global standard for regulatory submissions to health authorities. It uses a structured digital format that improves efficiency and consistency across regions, although each region still has its own requirements. As the world’s
Taiwan continues to position itself as a fast-growing medical device market in Asia. Supported by a strong healthcare system, an aging population, and rising demand for advanced technologies, the sector is expanding steadily. With a projected compound annual growth rate
China’s medical device market continues to expand, driven by increasing demand and regulatory modernization. According to Fortune Business Insights, the market was valued at USD 40.31 billion in 2024 and is projected to reach USD 82.02 billion by 2032, with
Thailand is a rapidly growing medical device market in Southeast Asia, driven by an aging population and a thriving medical tourism industry. Millions of international patients seek advanced, affordable healthcare, driving demand for diagnostic tools, monitoring equipment, and long-term care
An IND submission is a critical step in drug development because it determines whether an investigational product can be tested in humans. Understanding what an IND is and meeting IND requirements early helps companies avoid regulatory delays and safety concerns
Biologic therapies are central to modern healthcare, enabling advanced treatments for cancer, autoimmune disorders, and rare genetic diseases. Products such as vaccines, monoclonal antibodies, and cell and gene therapies are now integral to many drug development programs. Before a biologic
Launching a medical device today requires more than proving safety and performance. Commercial success depends on whether the device can be used, reimbursed, and adopted within healthcare systems. This is where medical device market access becomes critical. Market access includes
Entering the United States medical device market requires more than a technically sound product. Manufacturers must demonstrate regulatory compliance, provide complete and internally consistent documentation, and communicate clearly with the U.S. Food and Drug Administration (FDA). For most Class II
Japan is one of the world’s largest and most sophisticated medical device markets. With a rapidly aging population, rising chronic disease burden, and substantial government investment in healthcare, demand for advanced medical technologies continues to grow. In 2024, Japan’s medical
A strong medical device regulatory strategy is essential for patient safety, product quality, and long-term market access. Regulatory authorities such as the U.S. Food and Drug Administration and the European Union Medical Device Regulation now apply stricter requirements to technical
The medical device industry is inherently global. Devices are often developed in one country, manufactured in another, and sold across multiple regions, each with its own regulatory and language requirements. As of 2025, the global medical devices market is valued
The European Union’s Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) have significantly increased regulatory expectations for medical device and IVD manufacturers. Beyond technical performance and clinical evidence, both regulations place strong emphasis on patient safety, usability, and
